Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That?
Autor: | Figen Öztürk, Mustafa Kula, Işın Soyuer, Ahmet Tutuş, Ummuhan Abdulrezzak |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2012 |
Předmět: |
lcsh:Medical physics. Medical radiology. Nuclear medicine
medicine.medical_specialty Pathology medicine.medical_treatment lcsh:R895-920 lcsh:Medicine Case Reports carcinoma Papillary thyroid cancer Renal cell carcinoma Biopsy medicine Carcinoma Radiology Nuclear Medicine and imaging Thyroid cancer Thyroid nodule lcsh:R5-920 medicine.diagnostic_test business.industry Thyroid lcsh:R medicine.disease renal cell medicine.anatomical_structure Thoracic vertebrae Thyroglobulin Radiology positron-emission tomography business lcsh:Medicine (General) |
Zdroj: | Molecular Imaging and Radionuclide Therapy, Vol 21, Iss 1, Pp 38-41 (2012) Molecular Imaging and Radionuclide Therapy |
ISSN: | 2147-1959 2146-1414 |
Popis: | We report the case of a 64-year-old man followed up for two years as suffering from differentiated thyroid cancer (DTC). In the patient’s follow up, despite thyroglobulin level and I-131 whole body scan results being normal, metastases were identified at the 4th thoracic vertebra corpus by MR. Histopathological findings were carcinoma metastases. F-18 FDG PET/CT showed increased metabolic activity in the right renal mass, bilaterally in the surrenal gland, multiple lymph nodes in the thoracic and abdominal para-aortic region and in multiple vertebral and pelvic bones. An excisional biopsy of the right renal mass was reported as renal cell carcinoma. Immunohistochemical staining performed retrospectively to the first thyroid preparation showed renal cell carcinoma metastases. Consequently, any patient who presents with a thyroid nodule can also be considered as possibly suffering from metastatic disease. F-18 FDG PET/CT can provide valuable information in finding the primary focus and metastases. Conflict of interest:None declared. |
Databáze: | OpenAIRE |
Externí odkaz: |